Cost-effectiveness of clopidogrel-aspirin versus aspirin alone for acute transient ischemic attack and minor stroke

• Main Authors: Pan, Y, Wang, A, Liu, G
• Other Authors: BIOMEDICAL ENGINEERING
• Format: Article
• Published: 2020
• Subjects: acetylsalicylic acid; acetylsalicylic acid plus clopidogrel; antithrombocytic agent; clopidogrel; ticlopidine; adult; anticoagulant therapy; Article; cerebrovascular accident; cohort analysis; controlled study; cost effectiveness analysis; female; health care cost; high risk patient; human; major clinical study; male; priority journal; probability; quality adjusted life year; sensitivity analysis; social behavior; transient ischemic attack; willingness to pay; world health organization; analogs and derivatives; China; combination drug therapy; comparative study; cost benefit analysis; drug cost; economics; Ischemic Attack, Transient; Markov chain; middle aged; outcome assessment; statistics and numerical data; Stroke; Aspirin; Cost-Benefit Analysis; Drug Costs; Drug Therapy, Combination; Female; Humans; Male; Markov Chains; Middle Aged; Outcome Assessment (Health Care); Platelet Aggregation Inhibitors; Quality-Adjusted Life Years; Ticlopidine
• Online Access: https://scholarbank.nus.edu.sg/handle/10635/182040
• Institution: National University of Singapore

10.1161/JAHA.114.000912